相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Linking inflammation and coagulation: novel drug targets to treat organ ischemia
Carla Jennewein et al.
CURRENT OPINION IN ANESTHESIOLOGY (2011)
AMP579 is revealed to be a potent A(2b)-adenosine receptor agonist in human 293 cells and rabbit hearts
Yanping Liu et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection
Gerd Heusch et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Infliximab attenuates early myocardial dysfunction after resuscitation in a swine cardiac arrest model
James T. Niemann et al.
CRITICAL CARE MEDICINE (2010)
Adenosine: An Old Drug Newly Discovered
Holger K. Eltzschig
ANESTHESIOLOGY (2009)
Collateral circulation Past and present
Wolfgang Schaper
BASIC RESEARCH IN CARDIOLOGY (2009)
Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-α levels following vascular injury
Hongjie Chen et al.
EXPERIMENTAL HEMATOLOGY (2009)
Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia
Peter Rosenberger et al.
NATURE IMMUNOLOGY (2009)
Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C
Atsushi Kuno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Hypoxia-inducible factor-1 is central to cardioprotection -: A new paradigm for ischemic preconditioning
Tobias Eckle et al.
CIRCULATION (2008)
Isolation and activation of human neutrophils in vitro.: The importance of the anticoagulant used during blood collection
Marisa Freltas et al.
CLINICAL BIOCHEMISTRY (2008)
Up-regulation of A2B adenosine receptor in A2A adenosine receptor knockout mouse coronary artery
Bunyen Teng et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Time to take myocardial reperfusion injury seriously
Derek J. Hausenloy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A2B adenosine receptor dampens hypoxia-induced vascular leak
Tobias Eckle et al.
BLOOD (2008)
Mechanisms of disease: Myocardial reperfusion injury
Derek M. Yellon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Adenosinergic cardioprotection: Multiple receptors, multiple pathways
Jason N. Peart et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors
Tobias Eckle et al.
CIRCULATION (2007)
Upregulation of the Water Channel Aquaporin-4 as a Potential Cause of Postischemic Cell Swelling in a Murine Model of Myocardial Infarction
Arne Warth et al.
CARDIOLOGY (2007)
Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice
Tobias Eckle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
The A2B adenosine receptor protects against inflammation and excessive vascular adhesion
Dan Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Role of adenosine receptors in volatile anesthetic preconditioning against neutrophil-induced contractile dysfunction in isolated rat hearts
GC Hu et al.
ANESTHESIOLOGY (2005)
Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes
ZQ Yang et al.
CIRCULATION (2005)
Adenosine A1/A2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning
G Kristo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
TNF alpha in ischemia/reperfusion injury and heart failure
R Schulz et al.
BASIC RESEARCH IN CARDIOLOGY (2004)
Vascular ischaemia and reperfusion injury
HK Eltzschig et al.
BRITISH MEDICAL BULLETIN (2004)
Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium:: Role of ectonucleotidases and adenosine A2B receptors
HK Eltzschig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion
JM Budde et al.
CARDIOVASCULAR RESEARCH (2000)
A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium
M Nakamura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
